Target intelligence / Profile preview

Spike Glycoprotein of SARS-CoV-2 (Omicron Variant) (S protein (Omicron))

Target
S protein (Omicron)
Molecular classification
Glycoprotein, Type I transmembrane protein
01

Overview

The spike glycoprotein (S protein) of the Omicron variant of SARS-CoV-2 is a large, trimeric, type I membrane protein essential for viral entry into host cells. It mediates attachment to the host cell receptor ACE2 and facilitates membrane fusion. The Omicron variant features numerous mutations in its spike protein, particularly in the receptor-binding domain (RBD), contributing to increased transmissibility and immune evasion. It is a major target for vaccines and therapeutics.

Other names
SARS-CoV-2 Spike protein (Omicron)Omicron Spike GlycoproteinS proteinSpike protein
02

Mechanism of action

Binding to ACE2 receptor to mediate viral entry. Target of neutralizing antibodies that block ACE2 binding or interfere with membrane fusion.

03

Biological functions

Viral entryReceptor binding (ACE2)Membrane fusionAntigen presentation
04

Disease associations

InfectionCOVID-19Viral pathogenesis
05

Safety considerations

Antibody-dependent enhancement (ADE)Potential for escape mutationsOff-target effects of spike-targeting therapies
06

Interacting drugs

Neutralizing antibodies

2 more in the full profile.

07

Biomarkers

Spike protein RBD mutations (for variant identification)Antibody titers against spike protein (for vaccine efficacy and immune protection)Viral load (correlated with spike protein expression)

Beyond the preview

Go deeper on Spike Glycoprotein of SARS-CoV-2 (Omicron Variant) (S protein (Omicron)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spike Glycoprotein of SARS-CoV-2 (Omicron Variant) (S protein (Omicron)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call